Austrian medicines authority positive towards biosimilar interchangeability

Author(s): Christoph Baumgärtel, MD, MSc

Abstract: Clinical evidence supporting biosimilar use is growing and for the first time, the Austrian Medicines and Medical Devices Agency takes a positive position on interchangeability. They now state that prescribing biosimilars to treatment-naïve patients and even a change from originator to biosimilar is appropriate, provided it is done under physician’s supervision. Submitted: 9 January […]

Read more →